Conolidine Proleviate for Joint Pain Treatment Fundamentals Explained
Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors inside the central anxious system, conolidine modulates alternate molecular targets. A Science Developments study observed that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which